P Seckinger

2.1k total citations
21 papers, 1.8k citations indexed

About

P Seckinger is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, P Seckinger has authored 21 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in P Seckinger's work include Immune Response and Inflammation (10 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (4 papers). P Seckinger is often cited by papers focused on Immune Response and Inflammation (10 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (4 papers). P Seckinger collaborates with scholars based in Switzerland, France and United States. P Seckinger's co-authors include Jean‐Michel Dayer, J M Dayer, Kim C. Williamson, H. Robson MacDonald, John W. Lowenthal, M. Fougereau, Jean-François Balavoine, Gonzalo J. Mazzei, Alan Shaw and J H Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

P Seckinger

21 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Seckinger Switzerland 17 1.0k 479 298 298 218 21 1.8k
H Loetscher Switzerland 14 1.2k 1.2× 514 1.1× 307 1.0× 223 0.7× 251 1.2× 15 1.9k
R. B. Nussenblatt United States 23 1.1k 1.1× 432 0.9× 300 1.0× 493 1.7× 387 1.8× 45 2.8k
Yojiro Kawabe Japan 22 898 0.9× 520 1.1× 247 0.8× 262 0.9× 181 0.8× 51 1.8k
S Gillis United States 18 1.1k 1.1× 405 0.8× 369 1.2× 185 0.6× 132 0.6× 33 1.8k
Gilbert J. Fournié France 25 1.0k 1.0× 608 1.3× 230 0.8× 425 1.4× 245 1.1× 75 2.3k
D Henriksen-DeStefano United States 10 959 0.9× 519 1.1× 355 1.2× 89 0.3× 218 1.0× 10 1.9k
K Nishioka Japan 30 888 0.9× 630 1.3× 305 1.0× 847 2.8× 218 1.0× 100 2.5k
S Suematsu Japan 9 973 1.0× 633 1.3× 683 2.3× 127 0.4× 145 0.7× 14 1.9k
Ralph Giorno United States 24 924 0.9× 374 0.8× 148 0.5× 444 1.5× 255 1.2× 54 2.0k
F.H.J. Gmelig-Meyling Netherlands 27 1.1k 1.1× 481 1.0× 209 0.7× 445 1.5× 244 1.1× 61 2.4k

Countries citing papers authored by P Seckinger

Since Specialization
Citations

This map shows the geographic impact of P Seckinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Seckinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Seckinger more than expected).

Fields of papers citing papers by P Seckinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Seckinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Seckinger. The network helps show where P Seckinger may publish in the future.

Co-authorship network of co-authors of P Seckinger

This figure shows the co-authorship network connecting the top 25 collaborators of P Seckinger. A scholar is included among the top collaborators of P Seckinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Seckinger. P Seckinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guinamard, Rodolphe, M. Fougereau, & P Seckinger. (1997). The SH3 Domain of Bruton's Tyrosine Kinase Interacts with Vav, Sam68 and EWS. Scandinavian Journal of Immunology. 45(6). 587–595. 64 indexed citations
2.
Salamero, Jean, Michel Fougereau, & P Seckinger. (1995). Internalization of B cell and pre‐B cell receptors is regulated by tyrosine kinase and phosphatase activities. European Journal of Immunology. 25(10). 2757–2764. 25 indexed citations
3.
Seckinger, P, Michèle Milili, Claudine Schiff, & Michel Fougereau. (1994). Interleukin‐7 regulates c‐myc expression in murine T cells and thymocytes: a role for tyrosine kinase(s) and calcium mobilization. European Journal of Immunology. 24(3). 716–722. 14 indexed citations
4.
Seckinger, P & M. Fougereau. (1994). Activation of src family kinases in human pre-B cells by IL-7.. The Journal of Immunology. 153(1). 97–109. 55 indexed citations
5.
Seckinger, P & Dayer Jm. (1992). Natural inhibitors of TNF.. PubMed. 56. 217–36. 7 indexed citations
6.
Conca, Walter, Philip E. Auron, P Seckinger, et al.. (1991). An interleukin 1 beta point mutant demonstrates that jun/fos expression is not sufficient for fibroblast metalloproteinase expression.. Journal of Biological Chemistry. 266(25). 16265–16268. 51 indexed citations
7.
Ferrante, Antonio, et al.. (1991). Inhibition of tumour necrosis factor alpha (TNF-alpha)-induced neutrophil respiratory burst by a TNF inhibitor.. PubMed. 72(3). 440–2. 14 indexed citations
8.
Seckinger, P, Elisabeth Vey, Gerardo Turcatti, Paul T. Wingfield, & Jean‐Michel Dayer. (1990). Tumor necrosis factor inhibitor: purification, NH2−terminal amino acidsequence and evidence for anti‐inflammatory and immunomodulatory activities. European Journal of Immunology. 20(5). 1167–1174. 34 indexed citations
10.
Seckinger, P, I Yaron, Frank A. Meyer, Michael Yaron, & Jean‐Michel Dayer. (1990). Modulation of the effects of interleukin‐1 on glycosaminoglycan synthesis by the urine‐derived interleukin‐1 inhibitor, but not by interleukin‐6. Arthritis & Rheumatism. 33(12). 1807–1814. 34 indexed citations
11.
Seckinger, P, Jenneke Klein‐Nulend, C. Alander, et al.. (1990). Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production.. The Journal of Immunology. 145(12). 4181–4184. 130 indexed citations
12.
Mazzei, Gonzalo J., P Seckinger, Jean‐Michel Dayer, & Alan Shaw. (1990). Purification and characterization of a 26‐kDa competitive inhibitor of interleukin 1. European Journal of Immunology. 20(3). 683–689. 63 indexed citations
13.
Seckinger, P, et al.. (1990). Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor.. Proceedings of the National Academy of Sciences. 87(13). 5188–5192. 115 indexed citations
14.
Plaetinck, Geert, et al.. (1989). Interleukin 1 and tumor necrosis factor enhance transcription from the SV40 early promoter in a T cell line. European Journal of Immunology. 19(5). 897–904. 11 indexed citations
15.
Wollheim, Claes B., et al.. (1989). A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets. Journal of Autoimmunity. 2(2). 163–171. 46 indexed citations
16.
Seckinger, P, et al.. (1989). Purification and biologic characterization of a specific tumor necrosis factor α inhibitor. Journal of Biological Chemistry. 264(20). 11966–11973. 253 indexed citations
17.
Seckinger, P, et al.. (1988). A human inhibitor of tumor necrosis factor alpha.. The Journal of Experimental Medicine. 167(4). 1511–1516. 222 indexed citations
18.
Seckinger, P & Jean‐Michel Dayer. (1987). Interleukin-1 inhibitors. Annales de l Institut Pasteur Immunologie. 138(3). 486–488. 37 indexed citations
19.
Seckinger, P, John W. Lowenthal, Kim C. Williamson, J M Dayer, & H. Robson MacDonald. (1987). A urine inhibitor of interleukin 1 activity that blocks ligand binding.. The Journal of Immunology. 139(5). 1546–1549. 290 indexed citations
20.
Balavoine, Jean-François, et al.. (1986). Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).. Journal of Clinical Investigation. 78(4). 1120–1124. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026